Dapagliflozin Effect on Erythropoiesis and Physical Fitness

Clinical trial NCT03423355 · WITHDRAWN

Trial details

NCT number: NCT03423355
Sponsor: University Hospital Tuebingen
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)

Start date: 2021-09-01
Primary completion: 2023-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.